US FDA approves breast cancer drug Kisqali: All about it

US FDA approves breast cancer drug Kisqali: All about it

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It targets high-risk HR-positive, HER2-negative stage II and III patients to prevent recurrence. Administered orally, the drug is taken for three weeks followed by a one-week break over three years. Read the article to know more. The US FDA…

Read More
Kalgoorlie’s power backups don’t have the juice for the whole town, FOI documents reveal

Kalgoorlie’s power backups don’t have the juice for the whole town, FOI documents reveal

Kalgoorlie’s backup generators can only provide a little over half the power the town actually needs, leaving residents vulnerable to lengthy blackouts when cut off from the state’s largest power grid. Kalgoorlie’s backup generators can only provide a little over half the power the town actually needs, leaving residents vulnerable to lengthy blackouts when cut off…

Read More